openPR Logo
Press release

Cancer Stem Cells Market - Prevention of Cancer and Cancer Treatment is Grabbing Attention of Cancer Researchers Globally

08-18-2016 09:02 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2733

Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively. Cancer stem cells (CSCs) have been tested on animal models and have also shown satisfactory results. However, human testing of cancer stem cells is still in its developing stage owing to stringent regulations and ethical issues associated with the same.

Worldwide cancer research activities are increasing rapidly owing to rising burden of mortality rate of cancer. Cancer stem cells are under research for various types of cancers such as lung cancer, breast cancer, colorectal cancer, skin cancer, brain cancer and bone cancer. Government initiative to boost the cancer research activities and availability of funds are some of the factors that are driving the global cancer stem cells (CSCs) market towards growth. While on the other hand, ethical issues involved in the stem cells research and stringent regulations to perform human trials are some of the factors that are restraining the growth of the global cancer stem cells (CSCs) market.

Geographically, global cancer stem cells market is segmented into North America, Europe, Asia Pacific and Rest of the world (RoW) regions. Currently, North America is leading the global cancer stem cells (CSCs) market and is followed by Europe. Factors such as highly developed research infrastructure, well defined regulatory norms, availability of research funds, availability of skilled research and healthcare professionals and supportive economy are driving the North American cancer stem cells market towards growth. Asia Pacific is lucrative market for cancer stem cells. Governments in the Asia Pacific countries mainly, India and China are taking initiative to boost the healthcare and biotechnology industry in the respective countries and thus, research and development activities in these countries are swiftly increasing.

Apart from India and China, Japan will play a significant role in the cancer stem cells market. Japanese government is heavily investing in healthcare industry in order to improve the healthcare facilities in the country and thus rising cancer treatment are expected to escalate the cancer stem cells treatment market in Japan. Latin American countries namely, Brazil, Mexico and Argentina are expected to contribute more to cancer stem cells market than other countries in the rest of the world region. While on the other hand, African countries and Middle Eastern countries are expected to show slow or no growth rate in the global cancer stem cells (CSCs) market.

Browse Full Research Report: http://www.transparencymarketresearch.com/cancer-stem-cells-market.html

Some of the major players in the global cancer stem cells market are AdnaGen GmbH, Advanced Cell Diagnostics, Inc., AVIVA Biosciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc. and Silicon Biosystems, S.p.A.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Stem Cells Market - Prevention of Cancer and Cancer Treatment is Grabbing Attention of Cancer Researchers Globally here

News-ID: 357052 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for CSCs

Cancer Stem Cells (CSCs) Market: A Guide to Understanding the Process
The global Cancer Stem Cells (CSCs) Market is projected to reach approximately USD 4.6 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.8% from 2024 to 2033. Cancer Stem Cells (CSCs) Market Overview The Cancer Stem Cells (CSCs) Market is experiencing rapid growth due to increasing cancer incidence and growing interest in targeted cancer therapies. CSCs are a subpopulation of tumor cells responsible for cancer initiation, progression, resistance
What is the Blue Skilled Worker CSCS Card?
The Blue skilled worker CSCS card cact training is crucial for demonstrating your abilities and obtaining complete site access if you have construction experience and a construction qualification. This card demonstrates that you meet the necessary safety and competency standards and is accepted throughout the industry. Experienced workers who have earned a relevant construction qualification, such as an NVQ Level 2 or its equivalent, are eligible to apply for
Cancer Stem Cells (CSCs) Market Outlook 2029: Presents Market Insights & Depth A …
Cancer stem cells (CSCs) market is anticipated to grow at a significant CAGR during the forecast period. Cancer stem cells (CSCs) are self-renewable cell types that are found in most types of liquid and solid cancers and are responsible for tumor beginning, its growth, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor-type dependent. At present, the therapeutics related to
Cancer Stem Cells (CSCs) Market Trends, Segmentation, Growth, Analysis and Forec …
The global cancer stem cells (CSCs) market is anticipated to grow at a significant CAGR during the forecast period. Cancer stem cells (CSCs) are self-renewable cell types that are found in most types of liquid and solid cancers and are responsible for tumor beginning, its growth, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor-type dependent. Cancer Stem Cells (CSCs)
Cancer Stem Cells (CSCs) Market Size, Share, Analysis, Industry Report and Forec …
The global cancer stem cells (CSCs) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cancer stem cells (CSCs) are self-renewable cell types that are found in most types of liquid and solid cancers and are responsible for tumor beginning, its growth, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor-type dependent. At present, the
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Resear …
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The analysts of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report have taken on the challenge of procuring insightful data from reliable resources and precisely segregating critical market dynamics, given the voluminous amount of information available.